Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 28, 2018 16:30 ET | Source: Entellus Medical, Inc.

Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers

MENLO PARK, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Entellus Medical Inc., now part of Stryker, today announced the publication of a multi-site market research study evaluating symptom severity...
June 19, 2018 08:00 ET | Source: Entellus Medical, Inc.

Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with medical therapy for treatment of persistent Eustachian tube dysfunction

PLYMOUTH, Minn., June 19, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced Otology and Neurotology published results from a study that compares balloon...
May 31, 2018 08:00 ET | Source: Entellus Medical, Inc.

Entellus Medical Announces Multi-Center Clinical Study Publication Confirming Nasal Obstruction Symptom Improvement from LATERA

MENLO PARK, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Entellus Medical, Inc., now a part of Stryker, today announced the publication of positive data from prospective, multicenter OR and Office...
December 07, 2017 08:15 ET | Source: Entellus Medical, Inc.

Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash

PLYMOUTH, Minn., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL) announced today a definitive merger agreement by which Stryker Corporation (NYSE:SYK) will acquire Entellus in...
November 14, 2017 16:05 ET | Source: Entellus Medical, Inc.

Entellus Medical to Participate in Upcoming Investor Conferences

PLYMOUTH, Minn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced the...
November 13, 2017 05:30 ET | Source: Entellus Medical, Inc.

Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation

PLYMOUTH, Minn., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that...
November 01, 2017 16:05 ET | Source: Entellus Medical, Inc.

Entellus Medical Announces Third Quarter 2017 Financial Results

PLYMOUTH, Minn., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering less invasive ENT products, today reported its financial...
October 30, 2017 08:30 ET | Source: Entellus Medical, Inc.

Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms with Latera® from Spirox®

PLYMOUTH, Minn., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL) today announced data from its first-in-human study of the Latera® absorbable nasal implant from Spirox®. The...
October 18, 2017 16:05 ET | Source: Entellus Medical, Inc.

Entellus Medical to Report Third Quarter 2017 Financial Results November 1, 2017

PLYMOUTH, Minn., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that it...
August 08, 2017 16:03 ET | Source: Entellus Medical, Inc.

Entellus Medical Announces New Employee Inducement Option Grants

PLYMOUTH, Minn., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that...